Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR known ✓ | P00533 | 1/20 | 0.67 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.67 |
| ▸ | GPR39 | O43194 | 1/20 | 0.67 |
| ▸ | CA2 | P00918 | 1/20 | 0.67 |
| ▸ | FYN | P06241 | 1/20 | 0.67 |
| ▸ | PPP3CA | Q08209 | 1/20 | 0.67 |
| ▸ | UBE2T | Q9NPD8 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL1136041 | 1.00 | — | — | |
| Water SCHEMBL1648681 | 1.00 | — | — | |
| Water SCHEMBL3477606 | 1.00 | — | — | |
| Water SCHEMBL21293770 | 1.00 | — | — | |
| Water SCHEMBL9279772 | 1.00 | — | — | |
| Water SCHEMBL8169894 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL27680957 | 0.87 | — | — | |
| Water SCHEMBL5739829 | 0.87 | — | — | |
| Ammonia Solution, Strong SCHEMBL28261841 | 0.87 | — | — | |
| Water SCHEMBL15794800 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118460414-A | Novel bacterial diatom co-culture medium and culture method | 中国水产科学研究院珠江水产研究所 | 2024-08-09 | — | — | CN | claimed |
| CN-119708980-A | Anticorrosive paint for high-speed guardrails and preparation method thereof | 山东高速新型建材有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-118460414-A | Novel bacterial diatom co-culture medium and culture method | 中国水产科学研究院珠江水产研究所 | 2024-08-09 | — | — | CN | disclosed |
| CN-108277153-B | Culture system suitable for northern haematococcus pluvialis and use method | 山东省海洋科学研究院(青岛国家海洋科学研究中心) | 2024-07-12 | — | — | CN | disclosed |
| US-11826981-B2 | Compositionally modulated zinc-manganese multilayered coatings | THE BOEING COMPANY (US) | 2023-11-28 | — | — | US | disclosed |
| US-20230304182-A1 | ELECTRODEPOSITED ZINC AND IRON COATINGS FOR CORROSION RESISTANCE | THE BOEING COMPANY | 2023-09-28 | — | — | US | disclosed |
| US-20230211582-A1 | COMPOSITIONALLY MODULATED ZINC-MANGANESE MULTILAYERED COATINGS | THE BOEING COMPANY | 2023-07-06 | — | — | US | disclosed |
| US-11661666-B2 | Electrodeposited zinc and iron coatings for corrosion resistance | THE BOEING COMPANY (US) | 2023-05-30 | — | — | US | disclosed |
| US-11633940-B2 | Compositionally modulated zinc-manganese multilayered coatings | THE BOEING COMPANY (US) | 2023-04-25 | — | — | US | disclosed |
| CN-115710235-A | Preparation method of probenazole | 天津北方食品有限公司 | 2023-02-24 | — | — | CN | disclosed |
| US-6503738-B1 | A scalable method for the production of highly purified plasmid DNA in Escherichia coli is described, which method includes growing plasmid-containing cells to a high biomass in exponential growth and lysing the cells by raising the pH | COBRA THERAPEUTICS LIMITED (GB) | 2003-01-07 | — | — | US | disclosed |
| US-20020142406-A1 | Generating polyhydroxyalkanoates; obtain genetically cells which express enzymes associated with generation of polyhydroxyalanoates, incubate with 3-hydroxypropionate or 3-hydroxyvalerate, recover polyhydroxyalkonoates | METABOLIX, INC. | 2002-10-03 | — | — | US | disclosed |
| US-6329183-B1 | PROVIDING DIOLS WHICH CAN BE CONVERTED INTO 3-HYDROXYPROPIONATE OR 3-HYDROXYVALERATE MONOMERS BY ENZYMES EXPRESSED BY ORGANISMS; CULTURING ORGANISMS TO PRODUCE POLYHYDROXYALKANOATES | METABOLIX, INC. | 2001-12-11 | — | — | US | disclosed |
| EP-1105514-A1 | POLYHYDROXYALKANOATE PRODUCTION FROM POLYOLS | METABOLIX, INC. (US) | 2001-06-13 | — | — | EP | disclosed |
| WO-2000008198-A1 | POLYHYDROXYALKANOATE PRODUCTION FROM POLYOLS | METABOLIX, INC. (US) | 2000-02-17 | — | — | WO | disclosed |
| US-5981735-A | CULTURING PLASMID-CONTAINING BACTERIAL CELLS TO HIGH BIOMASS IN EXPONENTIAL GROWTH, LYSING THE CELLS BY RAISING PH TO WHERE CHROMOSOMAL DNA IS DENATURED BUT PLASMID DNA IS REVERSIBLY RENATURED; DNA FOR GENE THERAPY | COBRA THERAPEUTICS LIMITED (GB) | 1999-11-09 | — | — | US | disclosed |
| EP-0880585-A1 | METHOD OF PLASMID DNA PRODUCTION AND PURIFICATION | Cobra Therapeutics Limited (GB) | 1998-12-02 | — | — | EP | disclosed |
| WO-1997029190-A1 | METHOD OF PLASMID DNA PRODUCTION AND PURIFICATION | COBRA THERAPEUTICS LIMITED (GB) | 1997-08-14 | — | — | WO | disclosed |
| CN-1034756-A | Improve the enzymic activity of organism and the method for synthesis capability | SCHERING AG (DE) | 1989-08-16 | — | — | CN | disclosed |
| US-4820388-A | SURFACTANT | RASCHIG AG (DE) | 1989-04-11 | — | — | US | disclosed |